Treatment-related TEAEs occurred in 7.6% of patients, with fatigue and somnolence being the most common (1.7% of patients each)
She added that there is "also concern for loss of bone density and muscle mass if protein intake and resistance activity are inadequate." "These medications do not distinguish between fat and lean mass, so without proper nutrition, patients can lose both," she said
Key Takeaways Studies have not shown a significant increase in pancreatitis rates among Ozempic users compared to those on a placebo, and events reported were generally mild
Expression of lipid peroxidation markers in the tear film and ocular surface of patients with non-sjogren syndrome: potential biomarkers for dry eye disease
FLS were lysed with 200 L of ATP-lysate reagent and centrifuged at 12,000 g for 10 min
Genetic Testing for Personalized Semaglutide Therapy The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
